Skip to content
ppharmaranks
Menu
Class IIOngoing

Clobazam Tablets 10mg recall

FDA recall D-0348-2024 · initiated Feb 12, 2024

By the pharmaranks editorial teamReviewed against the FDA (openFDA) sourcesUpdated Feb 28, 2024How we research

Micro Labs Limited recalled Clobazam Tablets 10mg in Feb 2024 — an FDA Class II recall (D-0348-2024) because CGMP Deviations: Out of specification for residual solvents.

May cause temporary or medically reversible harm; low probability of serious harm.

Why it was recalled

CGMP Deviations: Out of specification for residual solvents.

The manufacturing process itself

The FDA found the process itself out of compliance, usually before any defective product was identified.

This is a manufacturing or quality failure, not a finding that the medicine is unsafe to take — across every recall we hold, none was issued for that reason. It does not mean the batch was harmless.

Is your product affected? Check the lot number

A recall covers only specific lots. Find the lot number and expiration date on your package and compare them to the affected codes below — if yours is not listed, it was not part of this recall.

ZOAG043

Quantity recalled: 24,768 bottles

Details

Product
Clobazam Tablets 10mg, 100-count bottle, Rx Only, Manufactured by: Micro Labs Limited Goa-403 722, India. Manufactured for: Micro Labs USA, Inc. Somerset, NJ 08873. NDC 42571-315-01
Recalling company
Micro Labs
Classification
Class II
Status
Ongoing
Type
Voluntary: Firm initiated
Distribution
Nationwide in the USA
Initiated
Feb 12, 2024
FDA report date
Feb 28, 2024
What to do.If you have a recalled product, don't throw away questions — check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This page reproduces public FDA data and is not medical advice.

Frequently asked

Was Clobazam Tablets 10mg recalled?
Micro Labs Limited recalled Clobazam Tablets 10mg in Feb 2024 — an FDA Class II recall (D-0348-2024) because CGMP Deviations: Out of specification for residual solvents. May cause temporary or medically reversible harm; low probability of serious harm.
Why was Clobazam Tablets 10mg recalled?
Per the FDA enforcement record, the reason for recall D-0348-2024 was: CGMP Deviations: Out of specification for residual solvents.
Is a recalled Clobazam Tablets 10mg dangerous to take?
An FDA recall removes specific lots from the market for a defined reason and does not by itself mean the medicine is unsafe for everyone — your specific lot may never have been affected. May cause temporary or medically reversible harm; low probability of serious harm. Check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This reproduces public FDA data and is not medical advice.
Which lots of Clobazam Tablets 10mg are affected?
Distributed: Nationwide in the USA. The recall covers these lots — ZOAG043. Check the lot number and expiration date on your package against this list; if yours is not listed, it was not part of recall D-0348-2024.

Source: openFDA Drug Enforcement record D-0348-2024

← All drug recalls